Thermo Fisher (TMO) Stock Forecast & Price Target

Compare

4,917 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

TMO Analyst Ratings

Strong Buy

15 Buy

4 Hold

0 Sell

Based on 19 analysts giving stock ratings to

Thermo

Fisher

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

TMO Stock 12 Month Forecast

Average Price Target

$546.74

▲(11.93% Upside)

Based on 19 Wall Street analysts offering 12 month price targets for Thermo Fisher in the last 3 months. The average price target is $546.74 with a high forecast of $598.00 and a low forecast of $490.00. The average price target represents a 11.93% change from the last price of $488.48.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"395":"$395","620":"$620","451.25":"$451.3","507.5":"$507.5","563.75":"$563.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":598,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$598.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":546.74,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$546.74</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":490,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$490.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[395,451.25,507.5,563.75,620],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2024","6":"Feb<br/>2025","9":"May<br/>2025","12":"Aug<br/>2025","25":"Aug<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,463.04,473.4215384615385,483.80307692307696,494.1846153846154,504.56615384615384,514.9476923076924,525.3292307692308,535.7107692307693,546.0923076923077,556.4738461538461,566.8553846153847,577.2369230769231,587.6184615384616,{"y":598,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,463.04,469.47846153846154,475.91692307692307,482.35538461538465,488.7938461538462,495.2323076923077,501.6707692307692,508.1092307692308,514.5476923076923,520.9861538461539,527.4246153846154,533.863076923077,540.3015384615385,{"y":546.74,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,463.04,465.11384615384617,467.1876923076923,469.26153846153846,471.3353846153846,473.40923076923076,475.4830769230769,477.5569230769231,479.63076923076926,481.7046153846154,483.77846153846156,485.8523076923077,487.92615384615385,{"y":490,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":619.75,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":613.07,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":611.33,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":556.46,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 35,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":528.56,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":519.25,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 33,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":596.63,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 37,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":527.96,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":482.47,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 38,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":419.46,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":396.06,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 40,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":421.47,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 41,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":463.04,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 43,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$598.00

Average Price Target$546.74

Lowest Price Target$490.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Cira Diagnissa

TR | OpenAI - 4o

$539→$557

Buy

14.03%

Upside

Reiterated

08/19/25

AI Generated ArticleAI Generated Article

Matt Larew

William Blair

$598

Buy

22.42%

Upside

Initiated

08/18/25

Thermo Fisher initiated with an Outperform at William BlairThermo Fisher initiated with an Outperform at William Blair

Brandon Couillard

Wells Fargo

$565

Buy

15.66%

Upside

Reiterated

08/04/25

Thermo Fisher's Strong Market Position and Growth Drive Buy Rating

Jill Wu

CMB International Securities

$553

Buy

13.21%

Upside

Reiterated

07/28/25

Thermo Fisher's Strong Performance and Strategic Initiatives Justify Buy Rating Amid Industry Recovery

Sung Ji Nam

Scotiabank

$590

Buy

20.78%

Upside

Reiterated

07/28/25

Thermo Fisher (TMO) Gets a Buy from Scotiabank

Dan Leonard

UBS

$460→$500

Hold

2.36%

Upside

Reiterated

07/24/25

Thermo Fisher price target raised to $500 from $460 at UBSThermo Fisher price target raised to $500 from $460 at UBS

Catherine Ramsey Schulte

Robert W. Baird

$553→$567

Buy

16.07%

Upside

Reiterated

07/24/25

Thermo Fisher price target raised to $567 from $553 at BairdThermo Fisher price target raised to $567 from $553 at Baird

Tycho Peterson

Jefferies

$560

Buy

14.64%

Upside

Reiterated

07/24/25

Analysts Are Bullish on These Healthcare Stocks: Thermo Fisher (TMO), Viking Therapeutics (VKTX)

Patrick B Donnelly

Citi

$475→$500

Hold

2.36%

Upside

Reiterated

07/24/25

Analysts Offer Insights on Healthcare Companies: Icon (NASDAQ: ICLR), Merck & Company (NYSE: MRK) and Thermo Fisher (NYSE: TMO)

Eve Burstein

Bernstein

$560→$570

Buy

16.69%

Upside

Reiterated

07/24/25

Bernstein Remains a Buy on Thermo Fisher (TMO)Bernstein SocGen Group analyst Eve Burstein raised the price target on Thermo Fisher Scientific (NYSE: TMO) to $570.00 (from $560.00) while maintaining an Outperform rating.

Sidharth Sahoo

HSBC

$510

Hold

4.41%

Upside

Downgraded

07/24/25

Thermo Fisher downgraded to Hold from Buy at HSBCThermo Fisher downgraded to Hold from Buy at HSBC

Patrick Wood

Morgan Stanley

$550→$560

Buy

14.64%

Upside

Reiterated

07/24/25

Wall Street Analysts Are Bullish on Top Healthcare Picks

Daniel Arias

Stifel Nicolaus

$583

Buy

19.35%

Upside

Reiterated

07/24/25

Thermo Fisher (TMO) Receives a Buy from Stifel Nicolaus

Andrew Cooper

Raymond James

$535

Buy

9.52%

Upside

Reiterated

07/24/25

Thermo Fisher (TMO) Receives a Buy from Raymond James

Puneet Souda

Leerink Partners

$500

Buy

2.36%

Upside

Reiterated

07/24/25

Positive Outlook and Strategic Growth Plans Bolster Thermo Fisher's Stock RatingWe continue to be structurally positive on TMO and reiterate our $500 PT and OP rating.

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Cira Diagnissa

TR | OpenAI - 4o

$539→$557

Buy

14.03%

Upside

Reiterated

08/19/25

AI Generated ArticleAI Generated Article

Matt Larew

William Blair

$598

Buy

22.42%

Upside

Initiated

08/18/25

Thermo Fisher initiated with an Outperform at William BlairThermo Fisher initiated with an Outperform at William Blair

Brandon Couillard

Wells Fargo

$565

Buy

15.66%

Upside

Reiterated

08/04/25

Thermo Fisher's Strong Market Position and Growth Drive Buy Rating

Jill Wu

CMB International Securities

$553

Buy

13.21%

Upside

Reiterated

07/28/25

Thermo Fisher's Strong Performance and Strategic Initiatives Justify Buy Rating Amid Industry Recovery

Sung Ji Nam

Scotiabank

$590

Buy

20.78%

Upside

Reiterated

07/28/25

Thermo Fisher (TMO) Gets a Buy from Scotiabank

Dan Leonard

UBS

$460→$500

Hold

2.36%

Upside

Reiterated

07/24/25

Thermo Fisher price target raised to $500 from $460 at UBSThermo Fisher price target raised to $500 from $460 at UBS

Catherine Ramsey Schulte

Robert W. Baird

$553→$567

Buy

16.07%

Upside

Reiterated

07/24/25

Thermo Fisher price target raised to $567 from $553 at BairdThermo Fisher price target raised to $567 from $553 at Baird

Tycho Peterson

Jefferies

$560

Buy

14.64%

Upside

Reiterated

07/24/25

Analysts Are Bullish on These Healthcare Stocks: Thermo Fisher (TMO), Viking Therapeutics (VKTX)

Patrick B Donnelly

Citi

$475→$500

Hold

2.36%

Upside

Reiterated

07/24/25

Analysts Offer Insights on Healthcare Companies: Icon (NASDAQ: ICLR), Merck & Company (NYSE: MRK) and Thermo Fisher (NYSE: TMO)

Eve Burstein

Bernstein

$560→$570

Buy

16.69%

Upside

Reiterated

07/24/25

Sidharth Sahoo

HSBC

$510

Hold

4.41%

Upside

Downgraded

07/24/25

Thermo Fisher downgraded to Hold from Buy at HSBCThermo Fisher downgraded to Hold from Buy at HSBC

Patrick Wood

Morgan Stanley

$550→$560

Buy

14.64%

Upside

Reiterated

07/24/25

Wall Street Analysts Are Bullish on Top Healthcare Picks

Daniel Arias

Stifel Nicolaus

$583

Buy

19.35%

Upside

Reiterated

07/24/25

Thermo Fisher (TMO) Receives a Buy from Stifel Nicolaus

Andrew Cooper

Raymond James

$535

Buy

9.52%

Upside

Reiterated

07/24/25

Thermo Fisher (TMO) Receives a Buy from Raymond James

Puneet Souda

Leerink Partners

$500

Buy

2.36%

Upside

Reiterated

07/24/25

Positive Outlook and Strategic Growth Plans Bolster Thermo Fisher's Stock RatingWe continue to be structurally positive on TMO and reiterate our $500 PT and OP rating.

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Thermo Fisher

1 Month

xxx

Success Rate

12/19 ratings generated profit

Average Return

+1.09%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 63.16% of your transactions generating a profit, with an average return of +1.09% per trade.

3 Months

xxx

Success Rate

30/43 ratings generated profit

Average Return

+4.13%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 69.77% of your transactions generating a profit, with an average return of +4.13% per trade.

1 Year

Sung Ji NamScotiabank

Success Rate

16/19 ratings generated profit

Average Return

+15.83%

reiterated a buy rating last month

Copying Sung Ji Nam's trades and holding each position for 1 Year would result in 84.21% of your transactions generating a profit, with an average return of +15.83% per trade.

2 Years

xxx

Success Rate

16/19 ratings generated profit

Average Return

+32.04%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 84.21% of your transactions generating a profit, with an average return of +32.04% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

TMO Analyst Recommendation Trends

Rating

Apr 25

May 25

Jun 25

Jul 25

Aug 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, TMO has received 43 Buy Ratings, 7 Hold Ratings, and 0 Sell Ratings. TMO average Analyst price target in the past 3 months is 546.74.

Each month's total comprises the sum of three months' worth of ratings.

TMO Financial Forecast

TMO Earnings Forecast

Next quarter’s earnings estimate for TMO is $5.50 with a range of $5.47 to $5.62. The previous quarter’s EPS was $5.36. TMO beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.10% of the time in the same period. In the last calendar year TMO has Outperformed its overall industry.

TMO Sales Forecast

Next quarter’s sales forecast for TMO is $10.90B with a range of $10.85B to $11.00B. The previous quarter’s sales results were $10.86B. TMO beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 46.90% of the time in the same period. In the last calendar year TMO has Outperformed its overall industry.

TMO Stock Forecast FAQ

What is TMO’s average 12-month price target, according to analysts?

Based on analyst ratings, Thermo Fisher’s 12-month average price target is 546.74.

What is TMO’s upside potential, based on the analysts’ average price target?

Thermo Fisher has 11.93% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is TMO a Buy, Sell or Hold?

Thermo Fisher has a consensus rating of Strong Buy which is based on 15 buy ratings, 4 hold ratings and 0 sell ratings.

What is Thermo Fisher’s price target?

The average price target for Thermo Fisher is 546.74. This is based on 19 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $598.00 ,the lowest forecast is $490.00. The average price target represents 11.93% Increase from the current price of $488.48.

What do analysts say about Thermo Fisher?

Thermo Fisher’s analyst rating consensus is a Strong Buy. This is based on the ratings of 19 Wall Streets Analysts.

How can I buy shares of TMO?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Thermo Fisher (TMO) Stock Forecast & Price Target

TMO Analyst Ratings

TMO Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Thermo Fisher

TMO Analyst Recommendation Trends

TMO Financial Forecast

TMO Earnings Forecast

TMO Sales Forecast

TMO Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts